Skip to content
BuyandBill.com — Physician Administered Drug Pricing
  • Search
    • Search
    • HCPCS Code Lookup
    • NDC Lookup
    • Drug Price Lookup
  • Drug Codes
    • All Drug Codes
    • A Code
    • C Code
    • J Code
    • P Code
    • Q Code
    • S Code
    • CPT Vaccine Code
    • NOC Code
    • Administration Code

  • Coding References

    • CPT Administration Codes
    • HCPCS Modifiers
    • HCPCS Approvals
    • Medically Unlikely Edits
    • Place of Service Codes
    • NDC Listing Errors
    • SAD Exclusion List
    • Wastage Guidance

    Learn

    • Blog
    • Newsletter
    • Bobbi Buell's Newsletter
    • Glossary
    • Buy-and-Bill Basics
    • Biosimilars
    • 505(b)(2) Drugs
    • Drug Shortages

    Tools

    • Billing Calculator
    • Drug Comparative Graphing
    • Biosimilar Analysis
    • Part B Reimbursement

    Solutions

    • Drug Sponsorship
    • Drug Market Research
  • Subscription Options
    • Contact Us
    • Schedule Consultation
Login
  • Login
  • Register

Drug Alerts and Special Reports

Key reimbursement alerts for office-administered drugs — C-Code, J-Code, NDC, and NCCN alerts plus pricing updates, sent on behalf of pharma manufacturers.

Subscribe To Newsletter

Latest J-Code 09/21/2026

Permanent J-Code for FAVLYXA™ (fluorouracil) Injection: J9191

Read More
Latest FDA Approved 09/18/2026

Now Approved: New indication for TEVIMBRA(R) (tislelizumab-jsgr)

Read More
09/17/2026

AVLAYAH™ - Permanent HCPCS Code: J1757

Read More
J-Code 09/16/2026

Permanent J-Code for VYKOURA™ (leucovorin calcium) injection - J0644

Read More
J-Code 09/15/2026

Permanent J-Code for AVOPEF™ (etoposide) Injection - J9186

Read More
Q-Code 08/31/2026

Permanent Q-Code for ARMLUPEG® - Q5169

Read More
08/25/2026

Coverage Considerations Following Generic Entry of Venofer® and Injectafer®

Read More
NDC 08/24/2026

IMPORTANT Niktimvo™ (axatilimab-csfr) UPDATE: New NDCs and vial presentations

Read More
FDA Approved 07/27/2026

Now Approved: TEVIMBRA® 150 mg Single-Dose Vial

Read More
Biosimilar 07/23/2026

Samsung Bioepis Biosimilar Market Report 14th Edition, Q3 2026

Read More
Previous
12 … 17
Next

No alerts match your filters.

BuyandBill.com — Physician Administered Drug Pricing

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association).

CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved

Review us on Trustpilot
  • Email us [email protected]

Tools & Lookups

  • Search
  • HCPCS Code Lookup
  • NDC Lookup
  • Drug Price Lookup
  • Billing Calculator
  • Drug Comparative Graphing
  • Biosimilar Analysis
  • Part B Reimbursement
  • All Drug Codes

Coding References

  • CPT Administration Codes
  • HCPCS Modifiers
  • HCPCS Approvals
  • Medically Unlikely Edits
  • Place of Service Codes
  • NDC Listing Errors
  • SAD Exclusion List
  • Wastage Guidance (JZ & JW)

Learn

  • Blog
  • Newsletter
  • Bobbi Buell's Newsletter
  • Glossary
  • Buy-and-Bill Basics
  • Biosimilars
  • 505(b)(2)
  • Drug Shortages

Solutions

  • Drug Sponsorship
  • Drug Market Research

Company

  • About B&B
  • Subscription Options
  • Contact Us
  • Schedule a Consultation
  • Sitemap

© 2026 BuyandBill.com, a product of Alchemy Healthcare Solutions LLC. All rights reserved

  • Privacy Policy
  • Terms of Service
BuyandBill.com Analytics

Chart a whole drug class in one screen.

The Comparative Report puts ASP, the Medicare payment limit, WAC and AWP for up to 15 drugs on one timeline. Ten-plus years of monthly history, per HCPCS unit.

  • Four benchmarks plus the ASP/WAC ratio on the same axis
  • Prebuilt biosimilar, therapeutic-area and mechanism groups
  • Index to 100 to compare a $7 drug against a $90 one
  • Sortable table, reference multiples, saved reports, PDF export
See it in action

Included with BuyandBill Pro for $37/month billed annually.

Trastuzumab class, seven products

7 of 7products fell
▼ 90.0%steepest decline
8.6×price spread
The Comparative Report showing seven trastuzumab products: ASP range $7.73 to $66.27, median $27.16, prices fell 7 of 7, and all seven ASP curves plotted from 2015 to 2026.

Actual published ASP, Jan 2015 to Aug 2026.